Novavax | NVAX - Sales Revenues

Novavax reported $734.58M in Sales Revenues for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Sales Change
Adma Biologics ADMA:US USD 41.09M 7.18M
AstraZeneca AZN:LN USD 11.21B 225M
Astrazeneca AZN:US USD 11.21B 225M
GlaxoSmithKline GSK:LN GBP 7.38B 453M
Mannkind MNKD:US USD 72.12M 39.29M
Merk MRK:US USD 13.83B 1.13B
Novartis NVS:US USD 13B 159M
Pfizer PFE:US USD 24.29B 1.65B